Dorsopathy in general clinical practice

Time codes:
  • 01:04

    History of the name of the vertebral artery syndrome

  • 03:00

    Symptoms and differences in symptoms

  • 06:40

    The anatomy of the vertebral artery and the diagnosis of stenosis 

  • 09:47

    Stages of vertebrobasicular insufficiency

  • 12:00

    Differential diagnosis of patients with pathology of the vertebral artery

  • 13:02

    Treatment of muscle problems with vertebral artery syndrome

  • 14:40

    Drug that improve blood circulation - Mexidol®

  • 17:40

    The beginning of therapy and the use of multimodal drugs

  • 18:30

    Mexidol® as a multimodal drug.

Ostroumova Olga Dmitrievna – Doctor of Medical Sciences, Professor, Head. Department of Therapy and Polymorbid Pathology named after. Academician M.S. Vovsi FSBEI DPO RMANPE Ministry of Health of Russia

Anatoly Ivanovich Fedin – Doctor of Medical Sciences, Professor Emeritus, Head of the University Clinic of Neurology at the N.I. Pirogov Russian National Research Medical University, Honored Doctor of the Russian Federation

Announcement:

Physicians frequently encounter diseases and conditions known as "vertebral artery syndrome," "dorsopathies," and "vertebrobasilar insufficiency." The clinical picture is characterized by a combination of autonomic and ischemic symptoms, manifested by dizziness, double vision, and insomnia. It is crucial to distinguish and differentiate these complaints. If vertebrobasilar insufficiency is suspected, differential diagnosis must be performed with other conditions that can lead to vertebral artery pathology. Mexidol® is often prescribed to improve the patient's well-being and normalize blood circulation. Mexidol® dizziness through a multimodal mechanism and improves quality of life.

Block of articles on this topic

The effectiveness of Mexidol with transient ischemic attacks in the vertebral-baslar system in elderly patients with chronic brain ischemia

Author:
Yu. V. ABRAMENKO

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

Treatment of dizziness in elderly patients with chronic cerebrovascular pathology

Author:
S.N. DUMA

Research Institute of Therapy and Preventive Medicine-a branch of the Federal State University "Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Novosibirsk, Russia

The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)

Authors:
V.V. ZAKHAROV1, O.N. TKACHEV2,3, E.A. MKHITARYAN2,3, A.I. FEDIN2

The prospects for the use of Mexidol for the treatment of patients suffering from neurosenate hearing loss and cerebrovascular failure

Author:
N.L. KUNELSKAYA, Yu.V. LEVINA, E.S. YANYUSHKINA, D.S. OGORODNIKOV, E.V. LARIONOVA

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com